$REGN Income Statement | Understand Stock

$REGN

$811.53 +$3.86 (0.48%) Live

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue from contract with customer
Net product sales
Sanofi collaboration revenue
Collaboration revenue
Other revenue
Total revenue from contract with customer

Expenses:
Research and development
Acquired in-process research and development
Selling, general, and administrative
Cost of goods sold and of collaboration and contract manufacturing
Net product sales
Cost of collaboration and contract manufacturing
Other operating (income) expense, net
Total expenses
Income from operations
Other income (expense):
Other income (expense), net
Interest expense
Total other income (expense)
Income before income taxes
Income tax expense
Net income
Other comprehensive income (loss), net of tax:
Unrealized gain on debt securities
Gain (loss) on foreign currency translation
Unrealized gain on cash flow hedges
Comprehensive income
Net income per share - basic (in dollars per share)
Net income per share - diluted (in dollars per share)
Weighted average shares outstanding - basic (in shares)
Weighted average shares outstanding - diluted (in shares)

Comments